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93.2% and91.5%. TheQFThad58.3% sensitivity and95.3% speciﬁcity
in diagnosing children with latent TB. The commonest discordant
results were TST+ / QFT- in 15 of 141 children without TB, not
unexpected in this BCG-vaccinated population.
Conclusion: The QFT performed better than the TST in the diag-
nosis of tuberculosis. Although only moderately sensitive, they
were highly speciﬁc in ruling out TB and showed good concordance
in TB-negative children. Although a case may be made for using
both tests in BCG-vaccinated children, the higher costs and techni-
cal expertise required for the QFT do not support its use instead of
the cheaper and simpler TST in India.
http://dx.doi.org/10.1016/j.ijid.2016.02.739
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Background: The Xpert MTB/RIF PCR assay detects
M.tuberculosis and resistance to Rifampicin within 2-4 hours,
compared to the AFB culture that takes 4-8 weeks to provide the
same information. This study assessed the performance of the
Xpert MTB/RIF assay against the AFB culture and clinical case
deﬁnitions of intrathoracic and extrathoracic tuberculosis(TB), and
against type of specimen tested.
Methods & Materials: All children<16 years of age with sus-
pected TB seen in the Pediatric Department, Christian Medical
College, Vellore from May 2012-June 2015 and tested with Xpert
MTB/RIF assay and AFB cultures in the Department of Clinical
Microbiologywere included.Recordsand test resultswereaccessed
to classify children as conﬁrmed, probable or possible TB or TB
unlikely/not TB based on the 2014 NIH/WHO consensus and other
case deﬁnitions.
Results: 286 children with suspected TB (135 intrathoracic, 71
lymphadenitis, 51 meningitis and 28 abdominal) were reviewed.
41 of 52 children with culture-conﬁrmed TB had a positive Xpert
MTB/RIF assay (overall sensitivity 78.9%). 115 more children were
case-deﬁned TB, while 119 had no TB.
The sensitivity of the Xpert MTB/RIF assay against the AFB cul-
ture was 96% in intrathoracic TB, 78% for TB lymphadenitis, 67%
for TB abdomen and 46% for TB meningitis. The assay showed less
sensitivity against clinical case deﬁnitions, being 48% for intratho-
racic TB, 47% for TB lymphadenitis, 41% for TB abdomen and 19% for
TB meningitis. The assay diagnosed an additional 15 children with
intrathoracic TB, 11 children with TB lymphadenitis, and 3 and 2
children with TB abdomen and TB meningitis compared to the AFB
culture. Sensitivity was 100% for sputum specimens, intrathoracic
tissue and BAL samples, 90% for gastric aspirates, 78% for lymph
nodes, 67% for intra-abdominal tissue and 46% for CSF against the
AFB culture. Itwas 80% sensitive in detecting Rifampicin resistance.
The speciﬁcity of the assay in disease-negative children was 92%
for intra-thoracic and abdominal TB, 93% for TB lymphadenitis, and
100% for TB meningitis.
Conclusion: The Xpert MTB/RIF assay’s high sensitivity, speci-
ﬁcity and detection of Rifampicin resistance make it a good
point-of-care test for early diagnosis of childhood tuberculosis,
especially intrathoracic TB.
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Background: Extraintestinal pathogenic E. coli (ExPEC) cause
different infectious diseases in humans and animals, accounting
80% of urinary tract infections (UTIs), worldwide. Increase in the
prevalence of multidrug-resistant (MDR) E. coli and global dis-
semination of these clonal organisms is a signiﬁcant risk to the
public health. The present study investigates the prevalence, pop-
ulation structure, phylogenetic afﬁnities and molecular basis of
ESBL and antimicrobial resistance and also highlights the spread of
multi-drug resistant E. coli causing infections with varied clinical
spectrum
Methods&Materials: A total of 187 E. coli isolates frompatients
with different clinical complications were obtained from D.Y. Patil
Medical College, Pune, for this study. All the isolates were sub-
jected to phylogenetic grouping and speciﬁc sequence type (ST)
identiﬁcation. The ST131 strains were further evaluated for their
virulence gene proﬁles using PCR. Phenotypic and genotypic detec-
tions of antimicrobial resistance were carried out by disc diffusion
and PCR based methods, respectively. The clonality of ST131 iso-
lates with respect to strains of other sequence types was evaluated
by enterobacterial repetitive intergenic consensus PCR (ERIC-PCR).
Results: Phylogrouping of 187 E. coli isolates revealed that 78
(41.7%) isolates belonged to group A, 16 (8.6%) to group B1, 56
(29.9%) to group B2 and 37 (19.8%) to group D. Forty strains were
identiﬁed to belong to ST131. Virulence proﬁling of ST131 strains
demonstrated signiﬁcant prevalence of ﬁmH (90%), papC (82.5%),
hlyA (77.5%) traT (47.5%), sat (87.5%) and iucD (55%). The antibi-
otic resistance proﬁles of ST131 isolates showed high resistance to
ciproﬂaxin (92.5%), cotrimoxazole (67.5%) and tetracycline (62.5%).
A high proportion (60%) of these ST131 strainswasmultidrug resis-
tant and 95% were ESBL-positive. Of all the 40 ST131 strains, 42.5%
and 95% were positive for sulphonamide and streptomycin resis-
